Skip to main content
Clinical Trials/CTRI/2024/01/061711
CTRI/2024/01/061711
Completed
Phase 4

Comparative evaluation of Only buccal infiltration of 4% Articaine verses Buccal and palatal infiltration of 2% Lignocaine in patients with Symptomatic irreversible pulpitis in maxillary molars: A Randomized clinical study - NI

Dr Rohan Jiteshkumar Doshi0 sites182 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: 3- Administration
Sponsor
Dr Rohan Jiteshkumar Doshi
Enrollment
182
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 20, 2024
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Rohan Jiteshkumar Doshi

Eligibility Criteria

Inclusion Criteria

  • 1\. Systemically healthy both male and female patients between 18\-60 years of age will be included in the study.
  • 2\.Patients diagnosed with symptomatic irreversible pulpitis with or without apical periodontitis giving prolonged response to cold test in maxillary molars.
  • 3\.Patient should have actively experienced moderate to severe pain pre operatively on VAS scale above 4 is included in the study
  • 4\.A written informed consent will be taken from all the patients and only those patients ready to sign the consent form will be included in the study.

Exclusion Criteria

  • 1\.Patients allergic to local anesthetics or known allergy to Lignocaine and articaine will be excluded from study.
  • 2\.Pregnant and lactating patients will be excluded from study.
  • 3\.Patients taking any analgesics, antibiotics, sedatives, and antianxiety drugs on regular basis or before 24 hrs.of treatment will be excluded.
  • 4\.Patient having necrosed tooth with sinus tracts/local gum swelling around the affected tooth.
  • 5\. Patients with severe periodontitis and poor oral hygiene will be excluded from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials